Therefore, the aim of this review is to provide an overview of the present literature on FGF23 as a risk factor for type 2 diabetes, as well as the implications of deregulated FGF23 for cardiovascular risk in patients with diabetes. The gene discussed is FGF23; the disease is diabetes mellitus.